Recalls / Class I
Class ID-1334-2014
Class I— FDA's most serious classification, issued when there is a reasonable probability that use of or exposure to the drug will cause serious adverse health consequences or death.
Product
XZONE GOLD, 1 capsule blister 750 mg, Distributed by: XZONE, Orlando, FL.
- Affected lot / code info
- Lot # 130710GL, Exp. 07/31/2018
Why it was recalled
Marketed Without an Approved NDA/ANDA: These dietary supplements contain undeclared sildenafil, an analogue of sildenafil, and/or tadalafil.
Recalling firm
- Firm
- Schindele Enterprises dba Midwest Wholesale
- Notification channel
- Press Release
- Type
- Voluntary: Firm initiated
- Address
- 617 N Althea Ave, N/A, Nixa, Missouri 65714-7432
Distribution
- Quantity
- 175 blister packs
- Distribution pattern
- Distributed to PA, IL, TX, IA, GA, CT, FL, CA, LA, NY, MD, NV, and WI
Timeline
- Recall initiated
- 2014-01-09
- FDA classified
- 2014-05-20
- Posted by FDA
- 2014-05-28
- Terminated
- 2015-02-03
- Status
- Terminated
Source: openFDA Drug Enforcement endpoint. Recall record D-1334-2014. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.